Characterization of p53 p.T253I as a pathogenic mutation underlying Li-Fraumeni Syndrome
PLOS One · 2025
DOI: 10.1371/journal.pone.0320036 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Nathaniel C Holcomb und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Markey Cancer Center, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America. Hauptthemen laut MEDLINE: Li-Fraumeni Syndrome, Tumor Suppressor Protein p53, Adrenocortical Carcinoma, Mutation. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
We identified a germline TP53 c.758C > T (p.T253I) mutation in the TP53 tumor suppressor gene in a pediatric adrenocortical carcinoma (ACC) patient. Characteristic of pathogenic p53 mutations, we observed upregulation of total p53 protein levels in the patient’s ACC and concurrent suppression of the wild-type (WT) TP53 allele. As ACC can be associated with Li-Fraumeni Syndrome (LFS) and the mutation has not yet been linked to LFS, we sought to characterize the functionality of the T253I mutation. We acquired p53 -/- HEK293 cells and stably transduced them with GFP-tagged wild type (T253) or T253I p53 as well as two established pathogenic p53 mutants (C176Y and R213X). Compared to p53 WT, levels of T253I p53 increased while MDM2 levels decreased, suggesting a loss of MDM2-mediated regulation of T253I p53. Additionally, T253I showed a reduction in DNA damage responsive events, diminished DNA binding capabilities, and blunted transactivation capacity. These experimental data lead us to conclude that T253I represents a pathologic variant in TP53 that may predispose to LFS-associated tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Markey Cancer Center, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America.
- Department of Pediatrics, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America.
- Department of Pathology, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America.
- Department of Cancer Biostatistics, University of Kentucky College of Medicine, Lexington, Kentucky, United States of America.
ORCID-Profile: John A D'Orazio
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- National Cancer Institute
- National Institute of General Medical Sciences
- Kentucky Pediatric Cancer Research Trust Fund
Zitieren
APA
Holcomb, N. C., Harrington, A. M., Pu, H., Halilovic, B., Shelman, N. R., Zhang, S., Sears, C., Armstrong, T., Shelton, B., Corum, L., & D'Orazio, J. A. (2025). Characterization of p53 p.T253I as a pathogenic mutation underlying Li-Fraumeni Syndrome. PLOS One. https://doi.org/10.1371/journal.pone.0320036
Vancouver
Holcomb NC, Harrington AM, Pu H, Halilovic B, Shelman NR, Zhang S, et al. Characterization of p53 p.T253I as a pathogenic mutation underlying Li-Fraumeni Syndrome. PLOS One. 2025. doi:10.1371/journal.pone.0320036
BibTeX
@article{Holcomb2025,
author = {Holcomb, Nathaniel C and Harrington, Amanda M and Pu, Hong and Halilovic, Berina and Shelman, Nathan R and Zhang, Shulin and Sears, Catherine and Armstrong, Terra and Shelton, Brent and Corum, Lauren and D'Orazio, John A},
title = {Characterization of p53 p.T253I as a pathogenic mutation underlying Li-Fraumeni Syndrome},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0320036}
}
EUVIMED